子宫肌瘤的大小对双胎妊娠产科结局的影响

目的评估子宫肌瘤的大小对双胎妊娠产科结局的影响。方法选取在首都医科大学附属北京妇产医院建档并于2013年6月至2014年12月分娩的双胎妊娠合并子宫肌瘤患者为研究对象,记录肌瘤基本特征、产妇基本人口统计学特征、不良产科并发症及新生儿结局。结果共有51例患者纳入研究,其中34例肌瘤5 cm,17例至少有1个肌瘤≥5 cm。≥5 cm肌瘤者与5 cm肌瘤者相比,其基本人口统计学特征、肌瘤基本特征、不良产科并发症及新生儿结局差异均无统计学意义(P0.05)。≥5 cm肌瘤较5 cm肌瘤的变性率(58.82%vs 11.76%,P=0.001)明显增加。在孕中期,5 cm的肌瘤[(2.87±0.94)vs(3.45±1.22),P=0.018]明显增大。结论子宫肌瘤的大小对双胎妊娠产科结局的影响并不明显。在孕期,≥5 cm的肌瘤更易发生变性。5 cm的肌瘤在孕中期明显增大。     

早孕合并子宫肌瘤切除患者人工流产52例临床分析

目的探讨早孕合并子宫肌瘤切除术史患者的终止妊娠方式及子宫肌瘤切除对人工流产术(人流)并发症的影响。方法回顾性分析52例宫内妊娠6~10周合并子宫肌瘤、子宫腺肌瘤切除史患者的临床资料,同时选取60例无子宫肌瘤切除史早孕妇女为对照组,其中超声引导下人工流产30例、药物流产(药流)30例。结果 52例患者中宫腔镜下黏膜下肌瘤切除术10例,腹腔镜下29例,开腹13例;合并子宫腺肌7例;单发子宫肌瘤或腺肌瘤34例,多发子宫肌瘤18例;术前肌瘤最大直径1.5~11 cm,直径≥5 cm 40例,5 cm 12例;肌瘤切除距离妊娠时间8个月~15年;9例胎囊距离子宫浆膜层小于1 cm,均经MRI检查排除胎囊子宫肌层种植。23例采用超声引导下负压电吸人工流产术,均为一次成功,23例B超监视下,与其人流对照组比较,手术时间明显延长(P0.05),但术中出血量及术后残留率比较,差异无统计学意义(P0.05)。29例(包括胎囊距离子宫浆膜层小于1 cm 9例)药物流产术,残留率为27.59%,明显高于其药流对照组(P0.05)。结论对于早孕合并子宫肌瘤切除术史患者,超声引导下人流术定位准确、损伤性小,明显减少了术后残留,手术安全性高;对于可能存在子宫切口愈合欠佳者,药物流产可减少严重并发症的发生。     

子宫肌瘤剔除术后妊娠结局及相关影响因素

目的:分析影响子宫肌瘤术后妊娠的相关因素,比较不同手术方式的妊娠结局。方法:回顾分析2015年1月至2017年1月在南京医科大学附属无锡市妇幼保健院行子宫肌瘤剔除术的166例有生育要求的患者。采用单因素及多因素分析患者年龄、术前妊娠次数、是否合并不孕、肌瘤数目、最大肌瘤直径、肌瘤与子宫肌层的关系以及手术方式等对术后自然妊娠率的影响。比较腹腔镜子宫肌瘤剔除术组与经腹子宫肌瘤剔除术组的妊娠结局。结果:166例患者的术后总妊娠率48.80%,腹腔镜组、经腹组的术后妊娠率分别为44.00%(51/116)和60.00%(30/50),均未发生子宫破裂。患者年龄、最大肌瘤直径以及肌瘤位置与妊娠率相关(P0.05)。腹腔镜组与经腹组患者的妊娠率、流产率和产科并发症无显著差异(P0.05)。结论:年龄越大、最大肌瘤越大以及肌瘤位置越深越不利于妊娠,腹腔镜子宫肌瘤剔除术与经腹子宫肌瘤剔除术后妊娠结局相当。     

晚期妊娠合并子宫肌瘤193例临床分析

目的:探讨晚期妊娠合并子宫肌瘤术中处理方法.方法:回顾性分析2003年1月至2008年8月在本院治疗的193例晚期妊娠合并子宫肌瘤患者的临床资料,并按分娩方式、肌瘤大小、肌瘤类型进行分组,对其术中出血量、手术时间及术后住院天数进行比较.结果:剖宫产术前诊断妊娠合并子宫肌瘤104例,术前诊断率53.9%;剖宫产加子宫肌瘤剔除术术中出血量、手术时间和术后住院天数与单纯剖宫产相比差异无统计学意义(P>0.05);妊娠合并宫体肌瘤组手术时间较妊娠合并子宫下段及宫颈部肌瘤组明显缩短(P=0.007);>8 cm肌瘤组与≤2 cm肌瘤组、2～5 cm肌瘤组和>5～8 cm肌瘤组相比较,手术时间明显延长,术中出血量显著增多(P<0.05);黏膜下肌瘤组的手术时间、术中出血量和术后住院天数均较浆膜下肌瘤组显著延长(P<0.05).结论:对于妊娠合并子宫肌瘤患者,需尽早明确诊断,并根据子宫肌瘤的类型、位置及大小和患者的年龄及生育需求、有无其他严重妊娠合并症等综合考虑以决定分娩方式和术中处理方法.对直径>8cm的肌瘤、子宫下段及宫颈部肌瘤、黏膜下肌瘤的处理应谨慎.     

子宫腺肌病UAE治疗后妊娠及分娩的研究

目的:了解子宫腺肌病子宫动脉栓塞治疗(UAE)后患者的妊娠情况及结局,探讨该治疗方法对生育功能的影响。方法:对我院所完成的252例因子宫腺肌病行UAE的病例进行追踪观察,了解治疗后妊娠情况及结局。结果:①252例患者中有13例共16次妊娠,均为自然受孕。受孕时间为术后3~43个月,平均为13个月。②没有生育要求的208例患者中,有4例(4次)意外受孕:2例(2次)药物流产,2例(2次)行人工流产术。其中1例行人工流产术的患者取其绒毛组织作染色体检查正常。③有生育要求的44例患者中有9例12次妊娠(妊娠2次者1例,妊娠3次者1例),受孕率为27.3%(12/44)。其中足月顺产分娩3例,足月要求剖宫产和术中切除子宫1例,因胎膜早破早产要求行剖宫产1例,此5例均未发生产后出血,新生儿常规体格检查均未发现异常。自然流产4例(4次),均为孕4个月内胚胎停止发育。目前正在妊娠中患者1例,该患者行血液唐氏综合征筛查风险值为1/780,B超符合孕周,发育良好。结论:子宫腺肌病UAE治疗后可以正常受孕和分娩,但可能存在流产和早产的高危因素。     

单发肌壁间肌瘤患者IVF/ICSI生殖结局影响因素分析

目的:探究单发肌壁间肌瘤患者体外受精-胚胎移植/卵胞质内单精子显微注射(IVF-ET/ICSI)生殖结局的可能相关影响因素。方法:纳入2014年1月至2019年12月于山东大学附属生殖医院接受IVF/ICSI治疗的单发肌壁间肌瘤不孕症患者1348例,根据患者妊娠结局分为活产组(403例)与未活产组(945例)、妊娠组(634例)与未妊娠组(714例)。采用倾向性匹配评分(PSM)对活产组与未活产组患者进行1∶1条件匹配控制混杂因素,共386对患者匹配成功。两组间有统计学差异的协变量采用二元logistic回归分析。采用ROC曲线分析肌壁间肌瘤与生殖结局的关系,并评价其预测价值。通过计算约登指数找到截断值。结果:PSM匹配后,未获得活产组的宫腔操作史、子宫内膜压迫患者比例明显高于活产组,肌壁间肌瘤大小明显大于活产组,差异均有统计学意义(P<0.05);未妊娠组患者的子宫肌瘤直径显著大于妊娠组患者,差异均有统计学意义(P<0.05)。经二元logistic回归分析校正混杂因素后,宫腔操作史、子宫内膜受压及单发肌壁间肌瘤的直径对患者活产率存在显著影响(P<0.05);单发肌...     

孕妇子宫肌瘤并发症

育龄妇女20～25％有子宫肌瘤,但肌瘤的孕期发生率及并发症的准确资料尚未见报道。为对此种情况有所预见,作者复习了连续6,005例产科超声报告,发现121例子宫肌瘤。同期有12,472例分娩,28例已诊断子宫肌瘤者孕期因直接有关子宫肌瘤的并发症入院治疗共41次。此41次中有31次(25例患者)系中期妊娠或晚期妊娠,早期因痛性肌瘤综合征入院(7例伴阴道出血),患者均无发热及腹膜刺激征,仅1例有恶心呕吐。作者近2年半时间内用布洛芬治疗此症10侧,平均住院2.1天,且无复发,     

高强度聚焦超声治疗后子宫肌瘤患者妊娠情况分析

目的探讨高强度聚焦超声(HIFU)治疗对子宫肌瘤患者妊娠结局的影响。方法回顾性分析2010年10月至2017年10月,在遂宁市中心医院及重庆海扶医院接受HIFU治疗后妊娠的241例子宫肌瘤患者,观察HIFU消融治疗的疗效及患者妊娠结局。结果 HIFU治疗后,9例在HIFU治疗后2个月内妊娠,24例在治疗后2～4个月妊娠,33例患者术后4～6个月妊娠,175例在HIFU治疗6个月后妊娠。中位妊娠时间为治疗后9个月(1～26个月)。其中152例已顺利分娩;12例仍在妊娠中;3例异位妊娠,2例切口妊娠均经手术治疗;72例流产,包括人工流产66例次,自然流产6例次。人工流产原因包括:胚胎停止发育(8例),阴道流血增多(5例),甲状腺功能减退(1例),孕期使用药物担心胎儿畸形(6例),非计划妊娠(52例)。已分娩的152例中,147例148次足月分娩(1例足月分娩2次),5例早产。妊娠中及分娩时无子宫破裂发生,新生儿健康。HIFU治疗前,241例患者中136例有不良孕产史,HIFU治疗后这些患者中仅17例出现妊娠不良事件。HIFU治疗后自然流产率显著低于治疗前(P0.05)。结论 HIFU治疗有生育要求的子宫肌瘤患者是安全的,HIFU治疗有助于降低妊娠不良事件的发生率。     

子宫肌瘤红色变性67例临床分析

目的　研究子宫肌瘤红色变性的临床特征及妊娠期与非妊娠期子宫肌瘤红色变性的异同 ,探讨子宫肌瘤红色变性的发生机制。方法　对 1993～ 2 0 0 2年间手术治疗的 2 3 17例子宫肌瘤患者进行回顾性研究 ,并对行子宫肌瘤切除术的患者进行随访。结果　红色变性 67例 ,占同期 2 3 17例子宫肌瘤患者的 2 89% ,子宫肌瘤合并妊娠患者中 2 1 85%发生红色变性 ,而非妊娠期子宫肌瘤患者仅 1 87%发生红色变性 ,二者差异有统计学意义(P <0 0 0 1)。子宫肌瘤红色变性患者最常见症状为月经改变 ,出现在 2 9 85%的患者 ,2 0 90 %的患者有腹痛症状 ,17 91%的患者肌瘤增大较快 ,16 42 %有肌瘤压痛 ,14 93 %的患者白细胞计数升高。B超提示肌瘤个数妊娠组少于非妊娠组患者 ,最大肌瘤妊娠组 61 54%位于浆膜下 ,而非妊娠组 82 92 %位于肌壁间 ,妊娠组最大肌瘤直径明显小于非妊娠组 ,两组分别为 4 0 8cm和 7 2 8cm ,以上差异均有统计学意义 (P <0 0 0 1)。 97 0 1%的患者最大肌瘤发生变性。行肌瘤切除术的子宫肌瘤红色变性患者术后复发率与是否合并妊娠无明显相关 ,而与肌瘤个数有关 (P =0 0 2 4)。结论　妊娠期与非妊娠期子宫肌瘤患者红色变性发生率、肌瘤大小和部位等临床病理特征存在很大差异 ,考虑其红色变性发生机制     

妊娠合并系统性红斑狼疮患者孕期并发症及妊娠结局的临床分析

目的分析并探讨系统性红斑狼疮(SLE)患者的孕期并发症情况及妊娠结局。方法回顾性分析2000年1月至2010年3月北京大学人民医院收治的19例妊娠合并SLE患者的临床资料,对影响SLE合并妊娠并发症的相关因素和SLE不同妊娠时机的妊娠结局进行分析。结果 19例患者中11例(11/19,57.9%)出现了母儿并发症,4例重度子痫前期,1例流产,2例死胎,2例足月低出生体重,4例早产。无并发症组8例,两组患者的孕产次及孕前病程、分娩方式无明显差异,但无并发症组患者的年龄小于并发症组,分娩孕周明显延长,新生儿体重明显增加,两组差异有统计学意义(P=0.006);孕前病情的稳定程度对孕期母儿并发症的影响差异无统计学意义(P=0.633);但妊娠前病情稳定大于6个月的患者出现并发症的比例较低(6/12,50.0%vs5/7,71.4%)。3例妊娠期间诊断SLE的患者均在孕期或产后出现了严重的并发症,1例(1/3,33.3%)新生儿诊断为SLE;与孕前病情控制平稳6个月的患者相比,分娩孕周较小,新生儿体重较低(P0.05)。结论 SLE患者即使孕前病情控制平稳,妊娠后仍有可能出现严重的母儿并发症。在病情控制平稳后妊娠,孕期在产科和风湿科医师的共同严密监测下,坚持治疗,适时终止妊娠是改善母婴结局的关键。同时应注意提高对妊娠期SLE的诊断。     

Pregnancy outcomes following treatment for fibroids: uterine fibroid embolization versus laparoscopic myomectomy

PURPOSE OF REVIEW: The management of uterine fibroids in patients requiring treatment who desire future fertility remains controversial. Myomectomy has been the most common operative procedure to improve pregnancy rates and outcomes. Uterine fibroid embolization is an increasingly popular, minimally invasive treatment for fibroids. This review aims to provide critical analysis of available data on pregnancy following myomectomy and uterine artery embolization. RECENT FINDINGS: Patients with distorted uterine cavities due to submucosal fibroids of more than 2 cm have higher pregnancy rates following hysteroscopic resection. Pregnancy rates following myomectomy, both via laparoscopy and laparotomy, are in the 50-60% range, with most having good outcomes. Pregnancy rates following uterine artery embolization have not been established. Pregnancies following uterine artery embolization had higher rates of preterm delivery (odds ratio 6.2, 95% confidence interval 1.4-27.7) and malpresentation (odds ratio 4.3, 95% confidence interval 1.0-20.5) than pregnancies following laparoscopic myomectomy. SUMMARY: Both myomectomy and uterine artery embolization are safe and effective fibroid treatments, which should be discussed with appropriate candidates. Pregnancy complications, most importantly preterm delivery, spontaneous abortion, abnormal placentation and postpartum hemorrhage, are increased following uterine artery embolization compared to myomectomy. Although most pregnancies following uterine artery embolization have good outcomes, myomectomy should be recommended as the treatment of choice over uterine artery embolization in most patients desiring future fertility.     

Is myomectomy always the best choice for infertile women with symptomatic uterine fibroids?

Uterine artery embolization (UAE) is still regarded by most gynaecologists as contraindicated for women with symptomatic fibroids and otherwise unexplained infertility. For such patients, myomectomy is the usual option. We performed UAE as treatment of menorrhagia in an infertile woman with multiple subserosal and intramural fibroids who had previously failed multiple myomectomy. UAE resulted in durable symptom relief and substantial reduction of the uterine and fibroid size. The patient conceived spontaneously 20 months after UAE and progressed through pregnancy uneventfully. At 38 weeks of gestation, she underwent elective cesarean section and delivered a normal, healthy, 3180-g fetus without complications. The present case demonstrates that in symptomatic women with multiple subserosal and intramural fibroids and otherwise unexplained infertility, UAE may have symptomatic and reproductive outcomes superior to those of myomectomy.     

Fibroids and reproductive outcomes: a systematic literature review from conception to delivery

We examined the published relationship between uterine fibroids and reproductive outcomes. Submucosal fibroids had the strongest association with lower ongoing pregnancy rates, odds ratio, 0.5; 95% confidence interval, 0.3-0.8, primarily through decreased implantation. Cumulative pregnancy rates appeared slightly lower in patients with intramural fibroids 36.9% vs 41.1%, which may reflect biases in the literature; however, patients with intramural fibroids also experienced more miscarriages, 20.4% vs 12.9%. Adverse obstetric outcomes are rare and may reflect age or other differences in fibroid populations. Increased risk of malpresentation (odds ratio, 2.9; 2.6-3.2), cesarean (odds ratio, 3.7; 3.5-3.9), and preterm delivery (odds ratio, 1.5; 1.3-1.7) are reported; however, the incidence of labor dystocia was low (7.5%). There was no conclusive evidence that intramural or subserosal fibroids adversely affect fecundity. More prospective, controlled trials are needed to assess the effects of myomectomy. Good maternal and neonatal outcomes are expected in pregnancies with uterine fibroids.     

Vaginal expulsion of submucosal fibroids after uterine artery embolization. A report of three cases.

BACKGROUND: Since October 1996, at our fibroid center, we have been using the uterine artery embolization (UAE) procedure as a nonsurgical means to treat patients with fibroids and menorrhagia. We have performed this procedure on over 180 patients, 3 of whom experienced vaginal expulsion of submucosal fibroids from two to seven months later. CASES: A 37-year-old woman underwent UAE in November 1997 and expelled five submucosal fibroids two to three months later. A 43-year-old woman underwent UAE in August 1997 and expelled a submucosal fibroid four months later. A 46-year-old woman underwent UAE in April 1997 and expelled a submucosal fibroid seven months later. CONCLUSION: The use of UAE to treat patients with fibroids and menorrhagia is relatively new. Our experience has revealed that a significant percentage of patients who have had the embolization procedure will have reduction in menorrhagia and also in the volume of their fibroids. Complications and side effects have been few. Vaginal expulsion of submucosal fibroids can be viewed as a side effect of the procedure, and, to the best of our knowledge, these are the first reported cases of this postembolization occurrence.     

Clinical experience and fertility outcome after uterine artery occlusion and embolization

We evaluated the effects of uterine artery occlusion and embolization on clinical results and pregnancy outcome using information provided by the literature published in the MEDLINE biomedicine database. Uterine artery occlusion has the potential to compromise fibroid growth and its symptoms. There were only a few complications and adverse events associated with laparoscopic uterine artery occlusion (LUAO) and fibroid embolization. LUAO and uterine artery embolization (UAE) procedures are both minimally invasive operating procedures that preserve the uterus and ovarian blood supply and allow achievement of pregnancy in women with symptomatic fibroids. Women who became pregnant after uterine artery occlusion and embolization had increased risk of abortion, pre-term birth, malpresentation, and/or caesarean delivery.     

Fibroid volume, location and symptoms in women undergoing uterine artery embolization: does size or position matter?

OBJECTIVE: To investigate the relationship between MRI-determined uterine fibroid size and their location, and fibroid-related symptoms, including quality of life and sexual function, in women with symptomatic fibroids before uterine artery embolization (UAE). MATERIALS AND METHODS: Forty-six women underwent pelvic MRI within four weeks prior to UAE. The MRIs were analyzed and fibroid size and fibroid location were recorded. Women also completed a comprehensive self-report questionnaire within the four weeks prior to the procedure. The questionnaire (Short Form-36 (SF-36) and Female Sexual Function Index (FSFI), respectively, investigated the frequency of fibroid-related symptoms, as well as quality of life and sexual function. Pearson product moment correlation coefficients were used to examine relationships among variables, and ANOVAs were used to determine between-group difference. RESULTS: At baseline, women with symptomatic fibroids had worse quality of life and sexual function scores than healthy controls (p < .05). No fibroid-related symptoms, or aspects of quality of life or sexual function, were significantly correlated with either total uterine volume or largest fibroid volume. No significant differences with respect to fibroid-related symptoms were found between patients with or without subserosal or submucosal fibroids. CONCLUSIONS: Women with symptomatic fibroids pre-UAE had impaired quality of life and sexual function, but size and location of fibroids as determined by MRI were not related to fibroid-related symptoms, health-related quality of life, or sexual function.     

Fibroids and in-vitro fertilization: which comes first?

PURPOSE OF REVIEW: There is no consensus about the impact of uterine fibroids on fertility. This review explores past and recent studies that investigated the effects of submucosal, intramural, and subserosal fibroids on in-vitro fertilization (IVF) outcomes. We discuss the importance of proper evaluation of the uterus and endometrial cavity, and current options for optimal fibroid management in patients desiring fertility. RECENT FINDINGS: Several studies have reviewed the data on fibroids and infertility, further exploring this potential relationship. Two recent studies investigated reproductive outcomes before and after myomectomy, and IVF outcomes based on fibroid size and location. Both studies concluded that fibroids can impair reproductive outcomes. Several papers thoroughly reviewed medical and surgical management options for patients with fibroids and desired fertility. Although several medical therapies may reduce fibroid volume or decrease menorrhagia, myomectomy remains the standard of care for future fertility. Recent data identified an increased rate of pregnancy complications after uterine artery embolization compared with laparoscopic myomectomy. A new procedure, magnetic resonance imaging-guided focused ultrasound ablation, shows promise for the management of symptomatic fibroids, and possibly for the management of fibroids prior to pregnancy. As with embolization, more data are needed to evaluate postprocedure fertility and pregnancy outcomes. SUMMARY: Fibroid location, followed by size, is the most important factor determining the impact of fibroids on IVF outcomes. Any distortion of the endometrial cavity seriously affects IVF outcomes, and myomectomy is indicated in this situation. Myomectomy should also be considered for patients with large fibroids, and for patients with unexplained unsuccessful IVF cycles.     

Reproductive performance before and after abdominal myomectomy: a retrospective analysis

OBJECTIVE: To evaluate the results of abdominal myomectomy for intramural and subserosal fibroids and to identify factors that influence the reproductive outcome after surgery. DESIGN: Retrospective analysis of a case series. SETTING: An academic department specializing in gynecologic surgery. PATIENT(S): A total of 72 women with intramural and subserosal fibroids submitted to abdominal myomectomy who wished to conceive after surgery. INTERVENTION(S): Data were collected on clinical characteristics, surgical features, and obstetric history before and after surgery. MAIN OUTCOME MEASURE(S): Conception rate, pregnancy loss, and live birth rate before and after surgery, as well as postoperative probability of conception according to selected clinical and fibroid characteristics. RESULT(S): Conception rate was 28% before myomectomy and 70% after surgery. The corresponding figures were 69% and 25% for pregnancy loss and 30% and 75% for live birth rate, respectively. Age <30 years and number of fibroids removed were the only significant and independent predictors of obstetric outcome by multivariate analysis. CONCLUSION(S): Our results suggest that abdominal myomectomy might improve reproductive outcome in patients with intramural and subserosal fibroids. The reproductive performance was particularly good when the patients were younger than 30 years and had a single myoma to remove.     

Systematic review of pregnancy outcomes after fertility-preserving treatment of uterine fibroids

The aim of this study was to compare pregnancy outcomes after medical (ulipristal acetate [UPA]), surgical (myomectomy) and radiological (uterine artery embolization [UAE] or thermal ablation) therapy for fibroids in women. A systematic review was conducted and ScienceDirect, PubMed, Web of Science and Cochrane Library databases were thoroughly searched from 2000 to 2018. Only primary research was included with independent extraction of articles by two reviewers, using a standardized form. Data were available on 12 pregnancies after treatment with UPA, 1575 after myomectomy, 424 after UAE and 420 after fibroid ablation. Results after UPA therapy were not included in the statistical analysis owing to the limited number of cases; most were ongoing pregnancies. High rates of successful pregnancy were seen after myomectomy (75.6%) and fibroid ablation (70.5%), whereas pregnancies after UAE had the lowest live birth rates (60.6%) and highest miscarriage rates (27.4%) (both P < 0.001 versus other treatments). In conclusion, myomectomy is associated with better pregnancy outcomes than other fertility-preserving treatments for fibroids. At present, UPA is the only medical treatment for fibroids; however, the evidence on pregnancy outcome is limited. In the absence of randomized controlled trials, these data may be of benefit in advising patients about future pregnancy.     

Effects of the position of fibroids on fertility.

This prospective, controlled study was performed in order to evaluate whether the location of uterine fibroids may influence reproductive function in women and whether removal of the fibroid prior to conception may improve pregnancy rate and pregnancy maintenance. We examined 181 women affected by uterine fibroids who had been trying to conceive for at least 1 year without success. The main outcome measures were the pregnancy rate and the miscarriage rate. Among the patients who underwent myomectomy, the pregnancy rates obtained were 43.3% in cases of submucosal, 56.5% in cases of intramural, 40.0% in cases of submucosal-intramural and 35.5% in cases of intramural-subserosal uterine fibroids, respectively. Among the patients who did not undergo surgical treatment, the pregnancy rates obtained were 27.2% in women with submucosal, 41.0% in women with intramural, 15.0% in women with submucosal-intramural and 21.43% in women with intramural-subserosal uterine fibroids, respectively. Although the results were not statistically significant in the group of women with intramural and intramural-subserosal fibroids, this study confirms the important role of the position of the uterine fibroid in infertility as well as the importance of fibroids removal before the achievement of a pregnancy, to improve both the chances of fertilization and pregnancy maintenance.